150 related articles for article (PubMed ID: 36404143)
41. Intermittent Ex Vivo Lung Perfusion in a Porcine Model for Prolonged Lung Preservation.
Sakanoue I; Okamoto T; Ayyat KS; Yun JJ; Farver CF; Fujioka H; Date H; McCurry KR
Transplantation; 2024 Mar; 108(3):669-678. PubMed ID: 37726888
[TBL] [Abstract][Full Text] [Related]
42. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation.
Strüber M; Hohlfeld JM; Kofidis T; Warnecke G; Niedermeyer J; Sommer SP; Haverich A
J Thorac Cardiovasc Surg; 2002 Jan; 123(1):98-103. PubMed ID: 11782762
[TBL] [Abstract][Full Text] [Related]
43. Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death.
Sanchez PG; Bittle GJ; Williams K; Pasrija C; Xu K; Wei X; Wu ZJ; Griffith BP
Ann Surg; 2013 Mar; 257(3):534-41. PubMed ID: 23108122
[TBL] [Abstract][Full Text] [Related]
44. Hydrogen Flush After Cold Storage as a New End-Ischemic Ex Vivo Treatment for Liver Grafts Against Ischemia/Reperfusion Injury.
Tamaki I; Hata K; Okamura Y; Nigmet Y; Hirao H; Kubota T; Inamoto O; Kusakabe J; Goto T; Tajima T; Yoshikawa J; Tanaka H; Tsuruyama T; Tolba RH; Uemoto S
Liver Transpl; 2018 Nov; 24(11):1589-1602. PubMed ID: 30120877
[TBL] [Abstract][Full Text] [Related]
45. Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors.
Luh SP; Tsai CC; Shau WY; Shiau SY; Jan IS; Kuo SH; Yang PC
J Heart Lung Transplant; 2002 Feb; 21(2):251-9. PubMed ID: 11834354
[TBL] [Abstract][Full Text] [Related]
46. A porcine
Martens A; Ordies S; Vanaudenaerde BM; Verleden SE; Vos R; Verleden GM; Verbeken EK; Van Raemdonck DE; Claes S; Schols D; Chalopin M; Katz I; Farjot G; Neyrinck AP
Med Gas Res; 2017; 7(1):28-36. PubMed ID: 28480029
[TBL] [Abstract][Full Text] [Related]
47. Physiologic assessment of the ex vivo donor lung for transplantation.
Yeung JC; Cypel M; Machuca TN; Koike T; Cook DJ; Bonato R; Chen M; Sato M; Waddell TK; Liu M; Slutsky AS; Keshavjee S
J Heart Lung Transplant; 2012 Oct; 31(10):1120-6. PubMed ID: 22975103
[TBL] [Abstract][Full Text] [Related]
48. Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model.
Medeiros IL; Pêgo-Fernandes PM; Mariani AW; Fernandes FG; Unterpertinger FV; Canzian M; Jatene FB
Clinics (Sao Paulo); 2012 Sep; 67(9):1101-6. PubMed ID: 23018310
[TBL] [Abstract][Full Text] [Related]
49. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.
Becker S; Steinmeyer J; Avsar M; Höffler K; Salman J; Haverich A; Warnecke G; Ochs M; Schnapper A
Transpl Int; 2016 Jan; 29(1):88-97. PubMed ID: 26264867
[TBL] [Abstract][Full Text] [Related]
50. Transplantation of initially rejected donor lungs after ex vivo lung perfusion.
Wallinder A; Ricksten SE; Hansson C; Riise GC; Silverborn M; Liden H; Olausson M; Dellgren G
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1222-8. PubMed ID: 22995721
[TBL] [Abstract][Full Text] [Related]
51. Importance of left atrial pressure during ex vivo lung perfusion.
Linacre V; Cypel M; Machuca T; Nakajima D; Hashimoto K; Zamel R; Chen M; Iskender I; Dos Santos P; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2016 Jun; 35(6):808-14. PubMed ID: 27160496
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model.
Motoyama H; Chen F; Ohsumi A; Hijiya K; Okita K; Nakajima D; Sakamoto J; Yamada T; Sato M; Aoyama A; Bando T; Date H
J Heart Lung Transplant; 2013 May; 32(5):505-10. PubMed ID: 23499355
[TBL] [Abstract][Full Text] [Related]
53. Prone Positioning During Ex Vivo Lung Perfusion Influences Regional Edema Accumulation.
Ordies S; Frick AE; Claes S; Schols D; Verleden SE; Van Raemdonck DE; Neyrinck AP;
J Surg Res; 2019 Jul; 239():300-308. PubMed ID: 30901722
[TBL] [Abstract][Full Text] [Related]
54. Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation.
Halldorsson AO; Kronon M; Allen BS; Rahman S; Wang T; Layland M; Sidle D
Ann Thorac Surg; 1998 Sep; 66(3):877-84; discussion 884-5. PubMed ID: 9768945
[TBL] [Abstract][Full Text] [Related]
55. Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.
Charles EJ; Huerter ME; Wagner CE; Sharma AK; Zhao Y; Stoler MH; Mehaffey JH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
Ann Thorac Surg; 2016 Dec; 102(6):1845-1853. PubMed ID: 27614736
[TBL] [Abstract][Full Text] [Related]
56. Sevoflurane Attenuates Ischemia-Reperfusion Injury in a Rat Lung Transplantation Model.
Ohsumi A; Marseu K; Slinger P; McRae K; Kim H; Guan Z; Hwang DM; Liu M; Keshavjee S; Cypel M
Ann Thorac Surg; 2017 May; 103(5):1578-1586. PubMed ID: 28190546
[TBL] [Abstract][Full Text] [Related]
57. Acellular ex vivo lung perfusate silences pro-inflammatory signaling in human lung endothelial and epithelial cells.
Jeon JE; Huang L; Zhu Z; Wong A; Keshavjee S; Liu M
J Transl Med; 2023 Oct; 21(1):729. PubMed ID: 37845763
[TBL] [Abstract][Full Text] [Related]
58. Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.
Emaminia A; Lapar DJ; Zhao Y; Steidle JF; Harris DA; Laubach VE; Linden J; Kron IL; Lau CL
Ann Thorac Surg; 2011 Nov; 92(5):1840-6. PubMed ID: 22051279
[TBL] [Abstract][Full Text] [Related]
59. Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.
Stone ML; Sharma AK; Mas VR; Gehrau RC; Mulloy DP; Zhao Y; Lau CL; Kron IL; Huerter ME; Laubach VE
Transplantation; 2015 Dec; 99(12):2494-503. PubMed ID: 26262504
[TBL] [Abstract][Full Text] [Related]
60. Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury.
Arni S; Maeyashiki T; Latshang T; Opitz I; Inci I
Cells; 2021 Sep; 10(9):. PubMed ID: 34571948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
